nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A behavioral approach to the neurobiology of schizophrenia
|
Gaebel, W. |
|
1991 |
4 |
3 |
p. 257-258 2 p. |
artikel |
2 |
A carbamazepine augmentation trial in chronic nonresponsive schizophrenia
|
Meszaros, K. |
|
1991 |
4 |
3 |
p. 291- 1 p. |
artikel |
3 |
A comparison of two short term models for multiple family group treatment
|
Lukens, E.P. |
|
1991 |
4 |
3 |
p. 306- 1 p. |
artikel |
4 |
Activation tasks in neuroleptic-induced akathisia
|
Fleischhacker, W.W. |
|
1991 |
4 |
3 |
p. 363- 1 p. |
artikel |
5 |
Acute extrapyramidal syndromes: Clinical characteristics implicate different pathophysiologies
|
Casey, D.E. |
|
1991 |
4 |
3 |
p. 361- 1 p. |
artikel |
6 |
Adjunctive neuropsychological remediation in psychiatric rehabilitation: Program description and priliminary data
|
Jaeger, J. |
|
1991 |
4 |
3 |
p. 304-305 2 p. |
artikel |
7 |
Adult neuropsychological and brain morphological findings in a sample of schizophrenic patients studied with home movies made as children
|
Lewine, R. |
|
1991 |
4 |
3 |
p. 387- 1 p. |
artikel |
8 |
Age dependent changes in dopamine transporter binding and its relevance to schizophrenia
|
Hitri, A. |
|
1991 |
4 |
3 |
p. 346- 1 p. |
artikel |
9 |
Aggressive behavior and the use of seclusion/restraint in chronic schizophrenic patients
|
Dickerson, F. |
|
1991 |
4 |
3 |
p. 302- 1 p. |
artikel |
10 |
A magnetic resonance imaging study comparing treatment-refractory and treatment-responsive schizophrenics
|
Miller, D.D. |
|
1991 |
4 |
3 |
p. 406- 1 p. |
artikel |
11 |
Amphetamine: clinical response of chronic schizophrenics to a single oral dose
|
Bigelow, L.B. |
|
1991 |
4 |
3 |
p. 313- 1 p. |
artikel |
12 |
Analysis of cerebrospinal fluid monoamines in schizophrenic patients on and off neuroleptic treatment and compared with healthy controls
|
Kirch, D.G. |
|
1991 |
4 |
3 |
p. 349- 1 p. |
artikel |
13 |
An animal model of the schizophrenic hippocampus: an attempt to influence fetal hippocampal development by means of maternal viral infection
|
Scheibel, A.B. |
|
1991 |
4 |
3 |
p. 359-360 2 p. |
artikel |
14 |
An autoradiographic study of cholecystokinin receptors in the temporal lobe in post-mortem schizophrenic brains
|
Kerwin, R.W. |
|
1991 |
4 |
3 |
p. 348-349 2 p. |
artikel |
15 |
An electrophysiological investigation of the mechanism of action of the 5-HT2 antagonists ritanserin and MDL 28,133A on amphetamine induced slowing of A10 dopamine neurons
|
Sorensen, S.M. |
|
1991 |
4 |
3 |
p. 337-338 2 p. |
artikel |
16 |
Antibodies from patients with schizophrenia recognize a 68 kD neuronal protein
|
Kilidireas, C. |
|
1991 |
4 |
3 |
p. 371-372 2 p. |
artikel |
17 |
A phenomenological test of the validity of the deficit syndrome
|
Kirkpatrick, B. |
|
1991 |
4 |
3 |
p. 262- 1 p. |
artikel |
18 |
A preparation and fixation technique suitable for quantitative immunohistochemistry and autoradiography of human brain tissue
|
Potkin, S.G. |
|
1991 |
4 |
3 |
p. 359- 1 p. |
artikel |
19 |
Assessment and evaluation of extrapyramidal symptoms of remoxipride and haloperidol in acute treatment of schizophrenia
|
Blomqvist, M. |
|
1991 |
4 |
3 |
p. 314- 1 p. |
artikel |
20 |
Association of pineal gland calcification with neuroleptic dose in chronic schizophrenia
|
Sandyk, R. |
|
1991 |
4 |
3 |
p. 294- 1 p. |
artikel |
21 |
Asymmetries in attentional filtering in left and right visual fields in schizophrenic patients
|
Wigal, S.B. |
|
1991 |
4 |
3 |
p. 396- 1 p. |
artikel |
22 |
A trial of enriched social treatments: Design and outcome
|
Monroe-Blum, H. |
|
1991 |
4 |
3 |
p. 306-307 2 p. |
artikel |
23 |
A trial of L-dopa and molindone in schizophrenia
|
Clardy, J. |
|
1991 |
4 |
3 |
p. 315-316 2 p. |
artikel |
24 |
Atrophy of the cerebellar vermis: Relevance to the symptoms of schizophrenia
|
Sandyk, R. |
|
1991 |
4 |
3 |
p. 411-412 2 p. |
artikel |
25 |
A twin study of prenatal injury markers in psychosis: Timing the insult
|
Bracha, U.S. |
|
1991 |
4 |
3 |
p. 250- 1 p. |
artikel |
26 |
Auditory P300 topography and frontal activation in schizophrenia
|
Merrin, E.L. |
|
1991 |
4 |
3 |
p. 335- 1 p. |
artikel |
27 |
Axis II personality features and disorder in subjects in the New York high-risk project
|
Squires-Wheeler, E. |
|
1991 |
4 |
3 |
p. 284-285 2 p. |
artikel |
28 |
Backward masking deficits in schizophrenia: Implicating a mechanism
|
Green, M.F. |
|
1991 |
4 |
3 |
p. 384- 1 p. |
artikel |
29 |
Behavioral and biochemical effects of methylphenidate infusion in schizophrenic and nonschizophrenic patients
|
Sharma, R.P. |
|
1991 |
4 |
3 |
p. 356- 1 p. |
artikel |
30 |
Behavioral and hormonal response to serotonergic challenge in chronic schizophrenia patients
|
Lindenmayer, J.-P. |
|
1991 |
4 |
3 |
p. 351- 1 p. |
artikel |
31 |
Benzodiazepine responsivity in schizophrenia
|
Wolkowitz, O.M. |
|
1991 |
4 |
3 |
p. 296- 1 p. |
artikel |
32 |
Biochemical pharmacology of the atypical neuroleptic remoxipride
|
Kohler, C. |
|
1991 |
4 |
3 |
p. 319- 1 p. |
artikel |
33 |
Biologic indices of heterogeneity in schizophrenia: Relationship to psychopathology and treatment outcome
|
Lieberman, J. |
|
1991 |
4 |
3 |
p. 289-290 2 p. |
artikel |
34 |
Borna disease virus and schizophrenia: Preliminary results
|
Waltrip, R.W. |
|
1991 |
4 |
3 |
p. 374- 1 p. |
artikel |
35 |
BPRS symptom factors and sleep variables in schizophrenia
|
Benson, K.L. |
|
1991 |
4 |
3 |
p. 329-330 2 p. |
artikel |
36 |
Brain morphology in first episode schizophrenia
|
Lieberman, J. |
|
1991 |
4 |
3 |
p. 387-388 2 p. |
artikel |
37 |
Catecholamine metabolism in psychotic/schizophrenic patients
|
Maas, J.A. |
|
1991 |
4 |
3 |
p. 352- 1 p. |
artikel |
38 |
Central D2 dopaminergic receptor status in treatment responsive and treatment resistant schizophrenic patients as measured by 123I-IBZM single photon emission tomography (SPET)
|
Pilowsky, L.S. |
|
1991 |
4 |
3 |
p. 410- 1 p. |
artikel |
39 |
Cerebral atrophy, signal hyperintensities and ventricular volume in schizophrenia on MRI: Relationship to the presence or absence of tardive dyskinesia
|
Waddington, J.L. |
|
1991 |
4 |
3 |
p. 369- 1 p. |
artikel |
40 |
Cerebrospinal fluid concentrations of dopamine and serotonin metabolites in patients with schizophrenia and schizoaffective disorder: The significance of positive and negative symptoms
|
Risby, E.D. |
|
1991 |
4 |
3 |
p. 355- 1 p. |
artikel |
41 |
Changes of the mRNAs for two dopamine D2 receptor isoforms in rat brain by haloperidol or methamphetamine treatment
|
Sora, I. |
|
1991 |
4 |
3 |
p. 284- 1 p. |
artikel |
42 |
Characteristics of some auditory evoked potential (AEP) and field (AEF) responses (100 ms) in schizophrenia
|
Reeve, A. |
|
1991 |
4 |
3 |
p. 336- 1 p. |
artikel |
43 |
Characterization of genetically transmitted schizophrenia in Danish adoptees
|
Ingraham, L.J. |
|
1991 |
4 |
3 |
p. 279-280 2 p. |
artikel |
44 |
Characterization of positive and negative symptoms in the early course of schizophrenia
|
Ventura, J. |
|
1991 |
4 |
3 |
p. 270-271 2 p. |
artikel |
45 |
Chromosomal aberrations and schizophrenia
|
Bassett, A.S. |
|
1991 |
4 |
3 |
p. 248-249 2 p. |
artikel |
46 |
Chronic clozapine, but not typical antipsychotic agents, increase lymphocyte glucocorticoid receptors in schizophrenics
|
Lowy, M.T. |
|
1991 |
4 |
3 |
p. 351-352 2 p. |
artikel |
47 |
Chronicity, negative symptoms and cognitive disorders of psychotic patients: Implications for treatment
|
Kuipers, T. |
|
1991 |
4 |
3 |
p. 262-263 2 p. |
artikel |
48 |
Clinical and immunological correlates of antibrain IgG autoantibodies in schizophrenic patients
|
Ganguli, R. |
|
1991 |
4 |
3 |
p. 371- 1 p. |
artikel |
49 |
Clinical correlates of plasma HVA during neuroleptic withdrawal
|
Saltz, B.L. |
|
1991 |
4 |
3 |
p. 293-294 2 p. |
artikel |
50 |
Clozapine and tardive dyskinesia: Prospective data
|
Kane, J.M. |
|
1991 |
4 |
3 |
p. 364-365 2 p. |
artikel |
51 |
Clozapine treatment in schizophrenic outpatients: Preliminary results from a double-blind efficacy study
|
Breier, A. |
|
1991 |
4 |
3 |
p. 315- 1 p. |
artikel |
52 |
Cognitive deficits underlying verbal memory function in schizophrenic patients and controls
|
Yurgelun-Todd, D.A. |
|
1991 |
4 |
3 |
p. 396-397 2 p. |
artikel |
53 |
Cognitive impairment and symptomatology associated with postdexamethasone cortisol concentrations in unmedicated schizophrenic patients
|
Newcomer, J.W. |
|
1991 |
4 |
3 |
p. 353- 1 p. |
artikel |
54 |
Comparison methods of quantification of spect brain images in psychiatric research
|
Fenn, D.S. |
|
1991 |
4 |
3 |
p. 403- 1 p. |
artikel |
55 |
Complications of pregnancy and delivery in relation to psychosis in adult life: A study using the perinatal mortality survey
|
Crow, T.J. |
|
1991 |
4 |
3 |
p. 253- 1 p. |
artikel |
56 |
Computer assisted volumetric measurements of MR brain images in schizophrenia
|
Shenton, M.E. |
|
1991 |
4 |
3 |
p. 413- 1 p. |
artikel |
57 |
Coping behavior in schizophrenic patients in terms of a situation/operation theory of stress and coping
|
Boker, W. |
|
1991 |
4 |
3 |
p. 300- 1 p. |
artikel |
58 |
Correlates of course and outcome in first-episode schizophrenia
|
Loebel, A. |
|
1991 |
4 |
3 |
p. 290- 1 p. |
artikel |
59 |
Correlates of suicidal ideation in post-psychotic depression
|
Siris, S.G. |
|
1991 |
4 |
3 |
p. 378- 1 p. |
artikel |
60 |
Correlation between changes in neurotransmitter receptor densities and chronic GABA agonist actions on haloperidol-induced vacuous chewing movements
|
Shirakawa, O. |
|
1991 |
4 |
3 |
p. 366-367 2 p. |
artikel |
61 |
Critical issues in the study of prepulse inhibition of acoustic startle: A measure of sensory gating related to mesolimbic dopamine activity
|
Schwarzkopf, S.B. |
|
1991 |
4 |
3 |
p. 392- 1 p. |
artikel |
62 |
CSF neurotransmitter changes during clozapine pharmacotherapy in schizophrenia
|
Risch, S.C. |
|
1991 |
4 |
3 |
p. 324-325 2 p. |
artikel |
63 |
Decreased substance P- and increased calcitonin gene-related peptide immunoreactivities in the cerebrospinal fluid of drug-naive schizophrenic patients
|
Fleischhacker, W.W. |
|
1991 |
4 |
3 |
p. 344-345 2 p. |
artikel |
64 |
Delta sleep inducing peptide-like immunoreactivity and sleep EEG results in schizophrenia
|
Peters, J.L. |
|
1991 |
4 |
3 |
p. 336- 1 p. |
artikel |
65 |
Dementia in elderly schizophrenic patients
|
Davidson, M. |
|
1991 |
4 |
3 |
p. 275-276 2 p. |
artikel |
66 |
Deterioration in premorbid functioning: A developmental model of negative symptoms
|
Kelly, M.E. |
|
1991 |
4 |
3 |
p. 261- 1 p. |
artikel |
67 |
Development of cognitive and electrophysiological measures of selective attention for genetic linkage studies of schizophrenia
|
Emmerson, R.Y. |
|
1991 |
4 |
3 |
p. 255- 1 p. |
artikel |
68 |
Development of drug-induced parkinsonism in elderly individuals receiving neuroleptics for the first time
|
Saltz, B.L. |
|
1991 |
4 |
3 |
p. 365-366 2 p. |
artikel |
69 |
Diagnosis of Blacks in a state system
|
Lawson, W.B. |
|
1991 |
4 |
3 |
p. 263- 1 p. |
artikel |
70 |
Differential effect of clozapine on psychopathology and cognitive dysfunction in treatment-resistant schizophrenics
|
Kenny, J.T. |
|
1991 |
4 |
3 |
p. 386-387 2 p. |
artikel |
71 |
Dimensionality of a neuropsychiatric soft sign battery
|
Faber, R. |
|
1991 |
4 |
3 |
p. 382-383 2 p. |
artikel |
72 |
Discriminating characteristics between schizophrenic and “schizoaffective” patients
|
Beasley, L. |
|
1991 |
4 |
3 |
p. 299- 1 p. |
artikel |
73 |
Disengagement of attention in schizophrenia
|
Strauss, M.E. |
|
1991 |
4 |
3 |
p. 394- 1 p. |
artikel |
74 |
Distribution of dopamine D-2 receptors in the monkey and human neocortex
|
Lidow, M.S. |
|
1991 |
4 |
3 |
p. 350-351 2 p. |
artikel |
75 |
Dopamine (D2) agonist receptor binding properties of [3H]U-86170
|
Lahti, R.A. |
|
1991 |
4 |
3 |
p. 319-320 2 p. |
artikel |
76 |
Dopamine-hydroxylase-like immunoreactivity in schizophrenia: Premorbid functioning and drug response
|
van Kammen, D.P. |
|
1991 |
4 |
3 |
p. 356- 1 p. |
artikel |
77 |
Editorial acknowledgement
|
Nasrallah, Henry A. |
|
1991 |
4 |
3 |
p. 246- 1 p. |
artikel |
78 |
EEG-brain mapping—A useful predictor of the efficiency of neuroleptic therapy in schizophrenic patients
|
Schellenberg, R. |
|
1991 |
4 |
3 |
p. 337- 1 p. |
artikel |
79 |
EEG photic driving in chronic PCP users, schizophrenic patients, and normal controls
|
Jin, Y. |
|
1991 |
4 |
3 |
p. 333-334 2 p. |
artikel |
80 |
Effect of neuroleptic withdrawal on the relationship of tardive dyskinesia and ventricular enlargement
|
Hoffman, W.F. |
|
1991 |
4 |
3 |
p. 364- 1 p. |
artikel |
81 |
Effect of typical and atypical antipsychotic drugs on the in vivo binding of [3H]N-methyl-spiperone to serotonin-2 and dopamine-2 receptors in rat brain
|
Stockmeier, C.A. |
|
1991 |
4 |
3 |
p. 326-327 2 p. |
artikel |
82 |
Effects of clozapine on cognition in patients with schizophrenia
|
Greenberg, R. |
|
1991 |
4 |
3 |
p. 385- 1 p. |
artikel |
83 |
Effects of famotidine, a histamine H2-receptor antagonist, on negative symptoms of schizophrenia
|
Kaminski, R. |
|
1991 |
4 |
3 |
p. 318-319 2 p. |
artikel |
84 |
Effects of leucotomy lesion size and location on personality and intellect
|
Swayze II, V.W. |
|
1991 |
4 |
3 |
p. 395- 1 p. |
artikel |
85 |
Effects of methamphetamine and MK-801 on dopamine in the striatum of awake rats: In vivo brain microdialysis and behavioral measures
|
Marshall, J.F. |
|
1991 |
4 |
3 |
p. 352- 1 p. |
artikel |
86 |
Efficacy and tolerability of clozapine in the treatment of 425 schizophrenic patients
|
Naber, D. |
|
1991 |
4 |
3 |
p. 322-323 2 p. |
artikel |
87 |
Efficacy and tolerability of the partial dopamine agonist SDZ HDC 912 in the treatment of schizophrenia
|
Naber, D. |
|
1991 |
4 |
3 |
p. 323- 1 p. |
artikel |
88 |
Elevated central levels of interleukin-2 in drug-free schizophrenic patients
|
Licinio, J. |
|
1991 |
4 |
3 |
p. 372- 1 p. |
artikel |
89 |
Epidemiology of schizophrenia in rural Ireland: Evidence for geographical variations in prevalence
|
Youssef, H.A. |
|
1991 |
4 |
3 |
p. 271- 1 p. |
artikel |
90 |
Ethnic differences in schizophrenia
|
Mance, R. |
|
1991 |
4 |
3 |
p. 264- 1 p. |
artikel |
91 |
Evaluating neuropsychological impairments in adult schizophrenic inpatients with a childhood age of onset: A preliminary report
|
Hoff, A.L. |
|
1991 |
4 |
3 |
p. 386- 1 p. |
artikel |
92 |
Evidence for an early antipsychotic effect of neuroleptics in patients with chronic schizophrenia
|
Stern, R.G. |
|
1991 |
4 |
3 |
p. 294-295 2 p. |
artikel |
93 |
Evidence for structural and functional pre-frontal impairments in schizophrenia
|
Raine, A. |
|
1991 |
4 |
3 |
p. 411- 1 p. |
artikel |
94 |
Evidence of early brain changes in subgroup of twins with schizophrenia
|
Torrey, E.F. |
|
1991 |
4 |
3 |
p. 285- 1 p. |
artikel |
95 |
Expressed Emotion (EE) and the targeted medication approach
|
Hanlon, T.E. |
|
1991 |
4 |
3 |
p. 304- 1 p. |
artikel |
96 |
Factors associated with medication noncompliance in schizophrenic patients
|
Albus, M. |
|
1991 |
4 |
3 |
p. 287- 1 p. |
artikel |
97 |
Family interaction vs. individual psychopathology
|
Goldstein, M.J. |
|
1991 |
4 |
3 |
p. 303-304 2 p. |
artikel |
98 |
Family involvement in the management of schizophrenia-evaluation of a new model
|
Katsching, H. |
|
1991 |
4 |
3 |
p. 305-306 2 p. |
artikel |
99 |
Forms of memory failure in schizophrenia
|
Gold, J.M. |
|
1991 |
4 |
3 |
p. 383-384 2 p. |
artikel |
100 |
From antibody to gene in schizophrenia: Methodology and progress report
|
Honer, W.G. |
|
1991 |
4 |
3 |
p. 278-279 2 p. |
artikel |
101 |
Frontal and right-left differences in schizophrenic vs normal subjects: A magnetic resonance brain imaging (MRI) study
|
DeMyer, M.K. |
|
1991 |
4 |
3 |
p. 402-403 2 p. |
artikel |
102 |
Functional brain topography by means of EEG mapping: Distinction of diagnosis and state in mental illness by means of a geometrical reconnaissance task
|
Gallhofer, B. |
|
1991 |
4 |
3 |
p. 332-333 2 p. |
artikel |
103 |
Functional brain topography by means of EEG mapping: Distinction of diagnosis and state in mental illness by means of an arythmetic task
|
Kunz, S. |
|
1991 |
4 |
3 |
p. 334- 1 p. |
artikel |
104 |
Gender differences in cognitive functioning and symptoms in schizophrenics
|
Addington, J. |
|
1991 |
4 |
3 |
p. 273- 1 p. |
artikel |
105 |
Gender differences in schizophrenia
|
Haas, G.L. |
|
1991 |
4 |
3 |
p. 277- 1 p. |
artikel |
106 |
Gender differences in the familial transmission of schizophrenia
|
Goldstein, J.M. |
|
1991 |
4 |
3 |
p. 258-259 2 p. |
artikel |
107 |
Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia
|
Childers, S.E. |
|
1991 |
4 |
3 |
p. 252- 1 p. |
artikel |
108 |
Genetic linkage analysis study of schizophrenia in Canadian families: Clinical assessment results
|
Bassett, A.S. |
|
1991 |
4 |
3 |
p. 249- 1 p. |
artikel |
109 |
Genetic linkage studies in schizophrenia using (CA)n repeat polymorphisms
|
Polymeropoulos, M.H. |
|
1991 |
4 |
3 |
p. 283- 1 p. |
artikel |
110 |
Genetic versus environmental rorschach variables in the Finnish adoptive family study of schizophrenia
|
Wahlberg, K.-E. |
|
1991 |
4 |
3 |
p. 309-310 2 p. |
artikel |
111 |
Haloperidol kinetics and clinical response
|
Conley, R. |
|
1991 |
4 |
3 |
p. 287- 1 p. |
artikel |
112 |
Hard neurologic signs and obstetric complications: Evidence for etiologic roles in schizophrenia
|
Kinney, D.K. |
|
1991 |
4 |
3 |
p. 261-262 2 p. |
artikel |
113 |
Heart rate variability in schizophrenia
|
Dalack, G.W. |
|
1991 |
4 |
3 |
p. 332- 1 p. |
artikel |
114 |
Ibotenic acid or ablation lesions of the frontal cortex do not alter the density or the affinity of D1 and D2 receptors in the corpus striatum or nucleus accumbens
|
Jaskiw, G.E. |
|
1991 |
4 |
3 |
p. 346-347 2 p. |
artikel |
115 |
Identification of subgroups of poorly responsive schizophrenics
|
Raymond, R. |
|
1991 |
4 |
3 |
p. 324- 1 p. |
artikel |
116 |
Immunohistochemistry of neuropeptides in tardive dyskinesia
|
Falkai, P. |
|
1991 |
4 |
3 |
p. 362- 1 p. |
artikel |
117 |
Impaired implicit memory in schizophrenia: A selective deficit?
|
Heinrichs, R.W. |
|
1991 |
4 |
3 |
p. 385- 1 p. |
artikel |
118 |
Impaired social functioning and schizophrenia: A familial association?
|
Brunke, J.J. |
|
1991 |
4 |
3 |
p. 250-251 2 p. |
artikel |
119 |
Implicit memory function in schizophrenia
|
Randolph, C. |
|
1991 |
4 |
3 |
p. 391- 1 p. |
artikel |
120 |
Implicit versus explicit memory in schizophrenia
|
Myles-Worsley, M. |
|
1991 |
4 |
3 |
p. 389- 1 p. |
artikel |
121 |
Increased percentages of T lymphocytes in the CSF of schizophrenic patients
|
McAllister, C.G. |
|
1991 |
4 |
3 |
p. 373- 1 p. |
artikel |
122 |
Index of first authors
|
|
|
1991 |
4 |
3 |
p. 417-420 4 p. |
artikel |
123 |
Information processing impairment in Finnish adopted-away offspring of schizophrenic mothers and control mothers
|
Moring, J. |
|
1991 |
4 |
3 |
p. 282- 1 p. |
artikel |
124 |
Initial experience with clozapine in Oregon's State Hospitals
|
Wilson, W.H. |
|
1991 |
4 |
3 |
p. 327-328 2 p. |
artikel |
125 |
Inside the black box called “expressed emotion”: A theoretical critique of the construct in psychiatric research
|
Jenkins, J.H. |
|
1991 |
4 |
3 |
p. 305- 1 p. |
artikel |
126 |
Insight and its related factors of chronic schizophrenic patients
|
Takai, A. |
|
1991 |
4 |
3 |
p. 309- 1 p. |
artikel |
127 |
Investigations of abnormal selective attention as a possible vulnerability marker for schizophrenia
|
Myles-Worsley, M. |
|
1991 |
4 |
3 |
p. 389-390 2 p. |
artikel |
128 |
Is delusional disorder different from schizophrenia?
|
Jeste, D.V. |
|
1991 |
4 |
3 |
p. 260- 1 p. |
artikel |
129 |
Kraepelinian schizophrenia: A replication in an independent sample
|
Frecska, E. |
|
1991 |
4 |
3 |
p. 257- 1 p. |
artikel |
130 |
Latent inhibition-based animal models: Implications of effects of phencyclidine and clozapine
|
Christison, G.W. |
|
1991 |
4 |
3 |
p. 331-332 2 p. |
artikel |
131 |
Lateral and third ventricular volumes in schizophrenics and their siblings: Effect of spectrum diagnosis
|
Olson, S.C. |
|
1991 |
4 |
3 |
p. 407-408 2 p. |
artikel |
132 |
Lateralized differences in reaction time in schizophrenic patients
|
Wigal, S.B. |
|
1991 |
4 |
3 |
p. 396- 1 p. |
artikel |
133 |
Left-handedness in schizophrenia is associated with increased impairment on the Luria-Nebraska neuropsychological battery
|
Faustman, W.O. |
|
1991 |
4 |
3 |
p. 383- 1 p. |
artikel |
134 |
Life events and prodromal symptoms in schizophrenia
|
Herz, M.I. |
|
1991 |
4 |
3 |
p. 289- 1 p. |
artikel |
135 |
Limbic system morphology in schizophrenia: A comparison of new post mortem and MRI data
|
Bogerts, B. |
|
1991 |
4 |
3 |
p. 400- 1 p. |
artikel |
136 |
Linkage analysis of six schizophrenia pedigrees with 150 DNA markers
|
Byerley, W. |
|
1991 |
4 |
3 |
p. 274-275 2 p. |
artikel |
137 |
Linkage map of schizophrenia 11q
|
Gill, M. |
|
1991 |
4 |
3 |
p. 258- 1 p. |
artikel |
138 |
Linkage studies of two new genes of neuropsychiatric interest
|
Kennedy, J.L. |
|
1991 |
4 |
3 |
p. 280- 1 p. |
artikel |
139 |
Lithium carbonate added to neuroleptics in treatment refractory schizophrenia
|
Meszaros, K. |
|
1991 |
4 |
3 |
p. 291-292 2 p. |
artikel |
140 |
Lithium in combination with perphenazine: Effect on plasma monoamine metabolities
|
Bowers, M.B. |
|
1991 |
4 |
3 |
p. 341-342 2 p. |
artikel |
141 |
Low amounts of the α subunit of GTP-binding protein Go in orbital frontal cortex of schizophrenic brain: Biochemical evidence of the hypofrontality hypothesis of schizophrenia
|
Okada, F. |
|
1991 |
4 |
3 |
p. 353-354 2 p. |
artikel |
142 |
Maintenance of grip-induced muscle tension as a marker variable in schizophrenia
|
Rosen, A.J. |
|
1991 |
4 |
3 |
p. 391-392 2 p. |
artikel |
143 |
MCPP effects in schizophrenic patients before and after typical and atypical neuroleptic treatment
|
Krystal, J.H. |
|
1991 |
4 |
3 |
p. 350- 1 p. |
artikel |
144 |
Measures of shifts in covert visual attention and eye movements in schizophrenia
|
Moran, M. |
|
1991 |
4 |
3 |
p. 388-389 2 p. |
artikel |
145 |
Measuring the character of community treatments for schizophrenics: Implications for efficacy and heterogeneity
|
Brekke, J.S. |
|
1991 |
4 |
3 |
p. 300-301 2 p. |
artikel |
146 |
Memory, frontal and other cognitive impairments in schizophrenia—A neuropsychological study
|
McKenna, P.J. |
|
1991 |
4 |
3 |
p. 388- 1 p. |
artikel |
147 |
Memory function in monozygotic twins discordant for schizophrenia
|
Goldberg, T.E. |
|
1991 |
4 |
3 |
p. 384- 1 p. |
artikel |
148 |
Mesial temporal volume changes on MRI in schizophrenic and affective patients
|
Pearlson, G.D. |
|
1991 |
4 |
3 |
p. 409- 1 p. |
artikel |
149 |
Monitoring service implementation in controlled services trials
|
Hargreaves, W.A. |
|
1991 |
4 |
3 |
p. 289- 1 p. |
artikel |
150 |
Morphometric study of prefrontal cortex and limbic structures in schizophrenia
|
Breier, A. |
|
1991 |
4 |
3 |
p. 400- 1 p. |
artikel |
151 |
MRI and PET studies in late life-onset schizophrenics
|
Pearlson, G.D. |
|
1991 |
4 |
3 |
p. 409-410 2 p. |
artikel |
152 |
MRI findings as a predictor of clozapine response
|
Jewart, R.D. |
|
1991 |
4 |
3 |
p. 406- 1 p. |
artikel |
153 |
99m-technetium single photon emission imaging in chronic schizophrenia and healthy volunteers
|
Ford, R. |
|
1991 |
4 |
3 |
p. 404- 1 p. |
artikel |
154 |
Negative schizophrenia as a variant of parkinsonism
|
Sandyk, R. |
|
1991 |
4 |
3 |
p. 266-267 2 p. |
artikel |
155 |
Negative symptoms, neuropsychological findings, and ventricular enlargement in schizophrenia
|
DeQuardo, J.R. |
|
1991 |
4 |
3 |
p. 254-255 2 p. |
artikel |
156 |
Neurodevelopmental indicators of vulnerability for schizophrenia
|
Walker, E.F. |
|
1991 |
4 |
3 |
p. 285-286 2 p. |
artikel |
157 |
Neuroendocrine determinants of disturbed water regulation in schizophrenia
|
Lawson, W.B. |
|
1991 |
4 |
3 |
p. 377-378 2 p. |
artikel |
158 |
Neuroendocrinological and neurochemical effects of the sigma ‘antagonist’ BMY 14802
|
Gudelsky, G.A. |
|
1991 |
4 |
3 |
p. 318- 1 p. |
artikel |
159 |
Neuroleptic-induced changes in gene expression in rat brain
|
Cohen, B.M. |
|
1991 |
4 |
3 |
p. 342-343 2 p. |
artikel |
160 |
Neurological soft signs in schizophrenic patients
|
Mohr, F. |
|
1991 |
4 |
3 |
p. 264-265 2 p. |
artikel |
161 |
Neurologic sequelae of psychogenic polydipsia
|
Conley, R. |
|
1991 |
4 |
3 |
p. 376- 1 p. |
artikel |
162 |
Neuropeptide Y like immunoreactivity in schizophrenia: Relationships with clinical measures
|
Peters, J. |
|
1991 |
4 |
3 |
p. 355- 1 p. |
artikel |
163 |
Neuropsychological deficit and symptomatology: Evidence for the heterogeneity of positive symptoms
|
O'Leary, D.S. |
|
1991 |
4 |
3 |
p. 266- 1 p. |
artikel |
164 |
Neuropsychological deviations in healthy relatives of schizophrenics
|
Maier, W. |
|
1991 |
4 |
3 |
p. 280-281 2 p. |
artikel |
165 |
Neuropsychological impairments are increased in siblings of schizophrenic patients
|
Pogue-Geile, M.F. |
|
1991 |
4 |
3 |
p. 390- 1 p. |
artikel |
166 |
Neuropsychological studies of first episode schizophrenia
|
Bilder, R.M. |
|
1991 |
4 |
3 |
p. 381-382 2 p. |
artikel |
167 |
Obstetric complications in schizophrenia
|
Davis, O.R. |
|
1991 |
4 |
3 |
p. 254- 1 p. |
artikel |
168 |
Oculomotor studies in schizophrenic patients with and without tardive dyskinesia
|
Thaker, G. |
|
1991 |
4 |
3 |
p. 368- 1 p. |
artikel |
169 |
Onset and premorbid clinical features of psychosis in the New York high-risk project
|
Bassett, A.S. |
|
1991 |
4 |
3 |
p. 273-274 2 p. |
artikel |
170 |
On the clinical profile of remoxipride—Experiences from a clinical trial programme in the acute treatment of schizophrenia
|
Lewander, T. |
|
1991 |
4 |
3 |
p. 321- 1 p. |
artikel |
171 |
Pathogenic traits in schizophrenia
|
Spohn, H.E. |
|
1991 |
4 |
3 |
p. 267-268 2 p. |
artikel |
172 |
Patterns of psychophysiological and acoustic responses and flat affect in schizophrenia
|
Sison, C.E. |
|
1991 |
4 |
3 |
p. 267- 1 p. |
artikel |
173 |
Persistent tardive dyskinesia, caudate atrophy on CT scan, and regional cerebral blood flow findings in schizophrenia
|
Mukherjee, S. |
|
1991 |
4 |
3 |
p. 365- 1 p. |
artikel |
174 |
PET studies of frontal lobe function during cognition
|
Berman, K.F. |
|
1991 |
4 |
3 |
p. 399- 1 p. |
artikel |
175 |
P300 event-related potential components and axis II-schizophrenia-related features and disorders
|
Squires-Wheeler, E. |
|
1991 |
4 |
3 |
p. 338- 1 p. |
artikel |
176 |
Pharmacological evaluation of sertindole: A new atypical neuroleptic
|
Skarsfeldt, T. |
|
1991 |
4 |
3 |
p. 326- 1 p. |
artikel |
177 |
Pharmacological properties of SDZ 212-327, a novel antipsychotic candidate
|
Markstein, R. |
|
1991 |
4 |
3 |
p. 322- 1 p. |
artikel |
178 |
Phase I trials of BMY 14802, a potential antipsychotic with affinity for sigma binding sites
|
Taylor, D.P. |
|
1991 |
4 |
3 |
p. 327- 1 p. |
artikel |
179 |
Phase of illness and suicide in schizophrenia
|
Weiden, P.J. |
|
1991 |
4 |
3 |
p. 379- 1 p. |
artikel |
180 |
Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients
|
Van Putten, T. |
|
1991 |
4 |
3 |
p. 295- 1 p. |
artikel |
181 |
Plasma homovanillic acid and drug response in schizophrenia
|
Diamond, B.I. |
|
1991 |
4 |
3 |
p. 343-344 2 p. |
artikel |
182 |
Plasma homovanillic acid concentrations decrease in responders, but not in non-responders, to neuroleptic treatment
|
Kahn, R.S. |
|
1991 |
4 |
3 |
p. 347- 1 p. |
artikel |
183 |
Plasma HVA correlates of attentional performance in unmedicated schizophrenics
|
Harvey, P.D. |
|
1991 |
4 |
3 |
p. 345-346 2 p. |
artikel |
184 |
Plasma level determination of haloperidol and reduced haloperidol in patients with treatment refractory schizophrenia by gas chromatography-mass spectrometry
|
Reed, K.L. |
|
1991 |
4 |
3 |
p. 293- 1 p. |
artikel |
185 |
Plasma level monitoring of depot neuroleptics
|
Marder, S.R. |
|
1991 |
4 |
3 |
p. 290-291 2 p. |
artikel |
186 |
Platelet [3H] dopamine uptake in patients with schizophrenia and non-schizophrenic psychoses: Its relationship to psychopathology
|
Copolov, D. |
|
1991 |
4 |
3 |
p. 343- 1 p. |
artikel |
187 |
Polydipsia-hyponatremia: Evidence for specific cerebral structural pathology and implications for the pathophysiology of schizophrenia
|
Kirch, D.G. |
|
1991 |
4 |
3 |
p. 377- 1 p. |
artikel |
188 |
Positron emission tomography study of phencyclidine users
|
Wu, J.C. |
|
1991 |
4 |
3 |
p. 415- 1 p. |
artikel |
189 |
-3PPP effects on local cerebral glucose utilization in the rat
|
Dixon, L.B. |
|
1991 |
4 |
3 |
p. 316-317 2 p. |
artikel |
190 |
Predicting skill acquisition in social skills training for schizophrenia and schizoaffective disorder: The role of memory and symptomatology
|
Mueser, K.T. |
|
1991 |
4 |
3 |
p. 307-308 2 p. |
artikel |
191 |
Prefrontal sulcal prominence is inversely related to treatment response to clozapine in schizophrenia
|
Friedman, L. |
|
1991 |
4 |
3 |
p. 317- 1 p. |
artikel |
192 |
Prenatal maldevelopment of the palm/thumb in schizophrenia: A monozygotic twins study
|
Bracha, H.S. |
|
1991 |
4 |
3 |
p. 274- 1 p. |
artikel |
193 |
Prevalence and risk factors of involuntary movement disorders in a neuroleptic treated population: A comparison between schizophrenic spectrum and non-schizophrenic spectrum patients
|
Smeraldi, E. |
|
1991 |
4 |
3 |
p. 367-368 2 p. |
artikel |
194 |
Prolactin bioassay in schizophrenic patients on neuroleptic medication
|
Warner, M.D. |
|
1991 |
4 |
3 |
p. 295-296 2 p. |
artikel |
195 |
Psychoactive substance abuse assesment in schizophrenics
|
Dixon, L.B. |
|
1991 |
4 |
3 |
p. 382- 1 p. |
artikel |
196 |
Pursuit eye movement dysfunction in schizophrenia: Characteristics of oculomotor disturbance and diagnostic specificity
|
Sweeney, J.A. |
|
1991 |
4 |
3 |
p. 339- 1 p. |
artikel |
197 |
Qualitative and quantitative assessment of pre-alpha-cell clusters in the entorhinal cortex of schizophrenics. A neurodevelopmental model of schizophrenia?
|
Falkai, P. |
|
1991 |
4 |
3 |
p. 357-358 2 p. |
artikel |
198 |
Quantification of relative haloperidol occupancy and effects in vivo with a simple dual detector probe
|
Jeffries, K.J. |
|
1991 |
4 |
3 |
p. 405-406 2 p. |
artikel |
199 |
Quantitative assessment of negative symptoms in chronic schizophrenic patients: Severity, response to treatment, and relationship to positive symptoms
|
Boronow, J.J. |
|
1991 |
4 |
3 |
p. 249-250 2 p. |
artikel |
200 |
Quantitative evaluation of astrocyte densities in schizophrenia
|
Falkai, P. |
|
1991 |
4 |
3 |
p. 358- 1 p. |
artikel |
201 |
Quantitative features of eye movement dysfunctions in schizophrenics
|
Levy, D.L. |
|
1991 |
4 |
3 |
p. 334-335 2 p. |
artikel |
202 |
Reduced cerebral glucose utilization in GABAergic nigral efferent target regions in intranigral isoniazid-induced vacuous chewing movements
|
Bachus, S.E. |
|
1991 |
4 |
3 |
p. 341- 1 p. |
artikel |
203 |
Reduced cerebral volume and increased third ventricular volume in schizophrenic patients: A quantitative magnetic resonance imaging study
|
Schwarzkopf, S.B. |
|
1991 |
4 |
3 |
p. 412- 1 p. |
artikel |
204 |
Regional brain glucose metabolism in neuroleptic naive first episode and chronic schizophrenic patients and normal controls at rest and after dopamine agonist and antagonist drugs
|
Cleghorn, J.M. |
|
1991 |
4 |
3 |
p. 401-402 2 p. |
artikel |
205 |
Regional glucose metabolism assessed by PET as a tool for studying clinical response to typical & atypical neuroleptics
|
Potkin, S.G. |
|
1991 |
4 |
3 |
p. 410-411 2 p. |
artikel |
206 |
Registered PET-MRI comparative study of normal volunteers performing a tone discrimination task: the impact of performance error on cortical surface metabolic activity patterns
|
Holcomb, H.H. |
|
1991 |
4 |
3 |
p. 404-405 2 p. |
artikel |
207 |
Reliability and validity of a depression scale for schizophrenics
|
Addington, D. |
|
1991 |
4 |
3 |
p. 247- 1 p. |
artikel |
208 |
Remoxipride therapy in poorly responsive schizophrenics
|
Conley, R. |
|
1991 |
4 |
3 |
p. 316- 1 p. |
artikel |
209 |
Risperidone in the treatment of acute exacerbation of chronic schizophrenia
|
Borison, R.L. |
|
1991 |
4 |
3 |
p. 314-315 2 p. |
artikel |
210 |
Sample bias in neurobiological studies of neuroleptic-naive psychotic subjects
|
Keks, N.A. |
|
1991 |
4 |
3 |
p. 260-261 2 p. |
artikel |
211 |
S(+)-aporphines as potential limbic-selective antipsychotic agents
|
Baldessarini, R.J. |
|
1991 |
4 |
3 |
p. 312- 1 p. |
artikel |
212 |
Schizophrenia and epilepsy: clinical and pathological studies
|
Stevens, J.R. |
|
1991 |
4 |
3 |
p. 373-374 2 p. |
artikel |
213 |
Schizophrenia and schizophreniform disorder: Is there a critical difference?
|
Nuechterlein, K.H. |
|
1991 |
4 |
3 |
p. 265-266 2 p. |
artikel |
214 |
Schizophrenia and social judgement: Why do schizophrenics get it wrong?
|
Cramer, P. |
|
1991 |
4 |
3 |
p. 301-302 2 p. |
artikel |
215 |
Schizophrenia neuroanatomy and theory falsification
|
Carpenter Jr., W.T. |
|
1991 |
4 |
3 |
p. 251- 1 p. |
artikel |
216 |
Schizotypal symptoms and information processing deficits in families of schizophrenic patients
|
Steinhauer, S.R. |
|
1991 |
4 |
3 |
p. 393- 1 p. |
artikel |
217 |
Second messenger imbalance hypothesis of schizophrenia
|
Kaiya, H. |
|
1991 |
4 |
3 |
p. 348- 1 p. |
artikel |
218 |
Segregation analysis of schizophrenia in nine multigenerational pedigrees
|
Plaetke, R. |
|
1991 |
4 |
3 |
p. 283- 1 p. |
artikel |
219 |
Sensory gating deficits in neonatally dopamine depleted animals: Evidence for involvement of mesolimbic dopamine supersensitivity
|
Schwarzkopf, S.B. |
|
1991 |
4 |
3 |
p. 392-393 2 p. |
artikel |
220 |
Serotonin binding sites and metabolites in the brain of schizophrenic suicide victims
|
Conley, R. |
|
1991 |
4 |
3 |
p. 376-377 2 p. |
artikel |
221 |
Serotonin receptor sensitivity in schizophrenia
|
Kahn, R.S. |
|
1991 |
4 |
3 |
p. 347-348 2 p. |
artikel |
222 |
Serotonin-2 receptors in the platelets of schizophrenic patients
|
Pandey, G.N. |
|
1991 |
4 |
3 |
p. 354- 1 p. |
artikel |
223 |
Serum cholinesterase and REM latency in schizophrenia
|
Keshavan, M. |
|
1991 |
4 |
3 |
p. 334- 1 p. |
artikel |
224 |
Should poor premorbid functioning be part of the negative syndrome?
|
Foerster, A. |
|
1991 |
4 |
3 |
p. 256-257 2 p. |
artikel |
225 |
Sleep encephalographic studies in schizophrenic patients: Comparison of neuroleptic-naive and previously-medicated patients with healthy controls
|
Taylor, S.F. |
|
1991 |
4 |
3 |
p. 339-340 2 p. |
artikel |
226 |
Smoking and tardive dyskinesia
|
Cohen, S. |
|
1991 |
4 |
3 |
p. 361-362 2 p. |
artikel |
227 |
Smooth pursuit eye movements in schizophrenia spectrum disorders: Familial vs episodic
|
Thaker, G. |
|
1991 |
4 |
3 |
p. 268-269 2 p. |
artikel |
228 |
Social interaction and schizophrenia: Problem, theory, and research
|
Flack Jr., W.F. |
|
1991 |
4 |
3 |
p. 303- 1 p. |
artikel |
229 |
Social signalling and schizophrenia: The significance of neurochemical and morphological abnormalities of the basolateral circuit
|
Deakin, J.F.W. |
|
1991 |
4 |
3 |
p. 357- 1 p. |
artikel |
230 |
Spectral EEG abnormalities following photic driving in schizophrenic patients
|
Jin, Y. |
|
1991 |
4 |
3 |
p. 333- 1 p. |
artikel |
231 |
Spin-spin relaxation time (T2) in schizophrenia
|
Pandurangi, A. |
|
1991 |
4 |
3 |
p. 408-409 2 p. |
artikel |
232 |
Striatal-thalamic disorder of cerebral metabolism in never-medicated schizophrenics
|
Buchsbaum, M.S. |
|
1991 |
4 |
3 |
p. 401- 1 p. |
artikel |
233 |
Structural brain imaging in partial trisomy chromosome 5 with schizophrenia
|
Honer, W.G. |
|
1991 |
4 |
3 |
p. 278- 1 p. |
artikel |
234 |
Studies in skin fibroblasts from chronic schizophrenic patients
|
Mahadik, S.P. |
|
1991 |
4 |
3 |
p. 372-373 2 p. |
artikel |
235 |
Suicide as a risk factor for tardive dyskinesia
|
Sandyk, R. |
|
1991 |
4 |
3 |
p. 366- 1 p. |
artikel |
236 |
Suicide behavior in patients with schizophrenia
|
Asnis, G.M. |
|
1991 |
4 |
3 |
p. 375- 1 p. |
artikel |
237 |
Suicide in schizophrenia: What do we know? where do we go?
|
Wagman, A.M.I. |
|
1991 |
4 |
3 |
p. 378-379 2 p. |
artikel |
238 |
Suicide in young adults with schizophrenic disorders: A prospective study
|
Cohen, L.J. |
|
1991 |
4 |
3 |
p. 375-376 2 p. |
artikel |
239 |
Tardive dyskinesia in the mentally retarded: Prevalence, risk factor and topographic comparison with a schizophrenic population
|
Cohen, S. |
|
1991 |
4 |
3 |
p. 362- 1 p. |
artikel |
240 |
Temporal lobe asymmetries as a clue to the aetiology of schizophrenia
|
Crow, T.J. |
|
1991 |
4 |
3 |
p. 402- 1 p. |
artikel |
241 |
Ten years of studies on P50 sensory gating: A review and considerations for future studies
|
Adler, L.E. |
|
1991 |
4 |
3 |
p. 329- 1 p. |
artikel |
242 |
Testing systems for assessment of negative symptoms in schizophrenia
|
Fenton, W.S. |
|
1991 |
4 |
3 |
p. 256- 1 p. |
artikel |
243 |
The ability of schizophrenics to perceive and cope with negative affect
|
Bellack, A.S. |
|
1991 |
4 |
3 |
p. 299-300 2 p. |
artikel |
244 |
The atypical neuroleptic, remoxipride, and prolactin response in the treatment of acute schizophrenia
|
Awad, A.G. |
|
1991 |
4 |
3 |
p. 311- 1 p. |
artikel |
245 |
The CBF and CMRO2 drug-naive and drug-treated schizophrenia, and presenile dementia: A study using PET
|
Takahashi, H. |
|
1991 |
4 |
3 |
p. 414- 1 p. |
artikel |
246 |
The clinical significance of medial temporal lobe hypoplasia in schizophrenia
|
Nasrallah, H.A. |
|
1991 |
4 |
3 |
p. 407- 1 p. |
artikel |
247 |
The clinical significance of neurophysiological deficits in schizophrenic patients
|
Braff, D.L. |
|
1991 |
4 |
3 |
p. 331- 1 p. |
artikel |
248 |
The 1962 Copenhagen high-risk study: 29 years after
|
Mednick, S.A. |
|
1991 |
4 |
3 |
p. 281- 1 p. |
artikel |
249 |
The correlation of the seasonality of schizophrenic births and stillbirths over a fifty-two year time period
|
Torrey, E.F. |
|
1991 |
4 |
3 |
p. 269- 1 p. |
artikel |
250 |
The cortical regulation of dopamine system responsivity: A hypothesis regarding its role in the etiology of schizophrenia
|
Grace, A.A. |
|
1991 |
4 |
3 |
p. 345- 1 p. |
artikel |
251 |
The deficit syndrome: functional and structural characteristics
|
Buchanan, R.W. |
|
1991 |
4 |
3 |
p. 400-401 2 p. |
artikel |
252 |
The effect of a hospital treatment model on the aftercare compliance rates of a SPMI patient group
|
Sullivan, T.B. |
|
1991 |
4 |
3 |
p. 308- 1 p. |
artikel |
253 |
The effect of early neuroleptic intervention on the course of schizophrenia
|
Wyatt, R.J. |
|
1991 |
4 |
3 |
p. 297- 1 p. |
artikel |
254 |
The effect of ritanserin on slow wave sleep deficits in schizophrenia
|
Benson, K.L. |
|
1991 |
4 |
3 |
p. 330- 1 p. |
artikel |
255 |
The effects of clozapine on dopamine, 5-HT, and glutamate release in the rat medial prefrontal cortex
|
Pehek, E.A. |
|
1991 |
4 |
3 |
p. 323-324 2 p. |
artikel |
256 |
The impact of neuroleptic medications on the incidence of tardive dyskinesia in an outpatient population
|
Glazer, W.M. |
|
1991 |
4 |
3 |
p. 363-364 2 p. |
artikel |
257 |
The influence of cigarette smoking on haloperidol dosing requirements
|
Perry, P.J. |
|
1991 |
4 |
3 |
p. 292- 1 p. |
artikel |
258 |
The Maine-Vermont longitudinal project: The world's only replication study over three decades
|
Harding, C.M. |
|
1991 |
4 |
3 |
p. 259- 1 p. |
artikel |
259 |
The measurement of unawareness of illness in schizophrenia
|
Amador, X.F. |
|
1991 |
4 |
3 |
p. 248- 1 p. |
artikel |
260 |
The neurodevelopmental and adult schizophrenias: Kraepelin lost and Kraepelin found
|
Murray, R.M. |
|
1991 |
4 |
3 |
p. 282-283 2 p. |
artikel |
261 |
The new selective dopamine D2 antagonist, remoxipride, in the treatment of acute schizophrenia: A Canadian multicenter trial
|
Awad, A.G. |
|
1991 |
4 |
3 |
p. 311-312 2 p. |
artikel |
262 |
The New York high-risk project: Comorbidity of axis I disorders in subjects at high risk for schizophrenia or major affective disorders and in low-risk subjects
|
Erlenmeyer-Kimling, L. |
|
1991 |
4 |
3 |
p. 276- 1 p. |
artikel |
263 |
The New York high-risk project: History of study, overview of marker findings to date and prevalence of axis I high and low risk subjects
|
Cornblatt, B. |
|
1991 |
4 |
3 |
p. 275- 1 p. |
artikel |
264 |
The pervasiveness of cognitive and behavioral treatment interventions in the schizophrenic's rehabilitation
|
Brenner, H.D. |
|
1991 |
4 |
3 |
p. 301- 1 p. |
artikel |
265 |
The pharmacological profile of U-86170F, a dopamine autoreceptor agonist
|
Lahti, R.A. |
|
1991 |
4 |
3 |
p. 320- 1 p. |
artikel |
266 |
The predictive utility of schizophrenic symptoms in patients with a recent episode of mania
|
Miklowitz, D.J. |
|
1991 |
4 |
3 |
p. 264- 1 p. |
artikel |
267 |
The Queensland follow-up study. Schizo-affective psychosis: Phenomenology and outcome
|
Varghese, F.T. |
|
1991 |
4 |
3 |
p. 270- 1 p. |
artikel |
268 |
The scope of the schizophrenic spectrum: results of a family study
|
Maier, W. |
|
1991 |
4 |
3 |
p. 263- 1 p. |
artikel |
269 |
The search for novel antipsychotics: Agents with a targeted activity in particular brain regions such as hippocampus—the example of savoxepine
|
Bischoff, S. |
|
1991 |
4 |
3 |
p. 313-314 2 p. |
artikel |
270 |
The subjective experience of negative symptoms and body image disturbance in schizophrenia
|
Cutbush, J. |
|
1991 |
4 |
3 |
p. 253-254 2 p. |
artikel |
271 |
The validity of wisconsin card sorting test factors as measures of dorsolateral prefrontal cortical function in schizophrenia and alcoholism
|
Sullivan, E.V. |
|
1991 |
4 |
3 |
p. 394-395 2 p. |
artikel |
272 |
Thought disorder in the siblings of schizophrenic patients
|
Hall, J.K. |
|
1991 |
4 |
3 |
p. 277-278 2 p. |
artikel |
273 |
Time course of psychopathologic and dyskinetic motor changes after blind neuroleptic withdrawal
|
Dixon, L. |
|
1991 |
4 |
3 |
p. 288- 1 p. |
artikel |
274 |
Towards DSM-IV schizophrenia: The application of three proposed schemata to prospectively collected data
|
Copolov, D.L. |
|
1991 |
4 |
3 |
p. 252-253 2 p. |
artikel |
275 |
To what degree do negative symptoms and social adaptation influence motivation towards regular participation in group therapy by schizophrenic outpatients?
|
Schmitz-Niehues, B. |
|
1991 |
4 |
3 |
p. 308- 1 p. |
artikel |
276 |
Treatment of borderline personality disorder with serotonin 1a agonist and psychotherapy
|
Wolf, M. |
|
1991 |
4 |
3 |
p. 328- 1 p. |
artikel |
277 |
Two nonhuman primate social colony models for screening novel antipsychotic candidates
|
Schlemmer Jr., R.F. |
|
1991 |
4 |
3 |
p. 325-326 2 p. |
artikel |
278 |
Use of a sigma receptor ligand, BMY 14802, for the treatment of schizophrenia
|
Gewirtz, G.R. |
|
1991 |
4 |
3 |
p. 317-318 2 p. |
artikel |
279 |
Using quantitative trait data to discriminate among genetic models of schizophrenia
|
Moldin, S.O. |
|
1991 |
4 |
3 |
p. 281- 1 p. |
artikel |
280 |
Validity of the deficit syndrome
|
Carpenter Jr., .T. |
|
1991 |
4 |
3 |
p. 251-252 2 p. |
artikel |
281 |
Vocal acoustic correlates of flat affect: Contrast with other negative signs and depression
|
Alpert, M. |
|
1991 |
4 |
3 |
p. 247-248 2 p. |
artikel |
282 |
Volumetric measurements of cerebral gray and white matter and cerebrospinal fluid space (CSF) in chronic schizophrenic patients and controls
|
Woods, B.T. |
|
1991 |
4 |
3 |
p. 414- 1 p. |
artikel |
283 |
Weight gain in clozapine treated schizophrenics
|
Lamberti, J.S. |
|
1991 |
4 |
3 |
p. 320-321 2 p. |
artikel |
284 |
Why isn't schizophrenia disappearing in Nottingham?
|
Harrison, G. |
|
1991 |
4 |
3 |
p. 259- 1 p. |
artikel |
285 |
2-year-outcome of intermittent vs. maintenance neuroleptic treatment in schizophrenia
|
Gaebel, W. |
|
1991 |
4 |
3 |
p. 288-289 2 p. |
artikel |